NeuroPace, Inc.
NPCE
$11.26
$0.1151.03%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | 19.18% | 28.20% | 16.63% | 25.23% | 40.84% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 19.18% | 28.20% | 16.63% | 25.23% | 40.84% |
Cost of Revenue | 18.16% | 34.48% | 12.87% | 16.61% | 12.07% |
Gross Profit | 19.51% | 26.05% | 18.06% | 28.64% | 53.87% |
SG&A Expenses | 4.33% | 3.89% | -1.27% | 12.48% | -2.61% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 8.91% | 13.08% | 4.61% | 12.63% | 1.83% |
Operating Income | 27.68% | 28.69% | 20.68% | 9.30% | 48.77% |
Income Before Tax | 15.32% | 24.87% | 17.65% | 13.98% | 44.37% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | 15.32% | 24.87% | 17.65% | 13.98% | 44.37% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 15.32% | 24.87% | 17.65% | 13.98% | 44.37% |
EBIT | 27.68% | 28.69% | 20.68% | 9.30% | 48.77% |
EBITDA | 28.06% | 29.20% | 20.93% | 9.32% | 48.89% |
EPS Basic | 24.12% | 33.60% | 27.30% | 23.68% | 48.46% |
Normalized Basic EPS | 16.55% | 33.62% | 27.29% | 23.68% | 49.48% |
EPS Diluted | 24.12% | 33.60% | 27.30% | 22.59% | 48.46% |
Normalized Diluted EPS | 16.55% | 33.62% | 27.29% | 23.68% | 49.48% |
Average Basic Shares Outstanding | 11.62% | 13.17% | 13.27% | 12.70% | 7.92% |
Average Diluted Shares Outstanding | 11.62% | 13.17% | 13.27% | 12.70% | 7.92% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |